QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 22 April 2008
doi: 10.1242/jcs.025726

This Article Figures Only Full Text Full Text (PDF) Supplementary Material All Versions of this Article: jcs.025726v1 121/10/1649    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ravikumar, B. Articles by Rubinsztein, D. C. Search for Related Content PubMed PubMed Citation Articles by Ravikumar, B. Articles by Rubinsztein, D. C. Social Bookmarking                         What's this?

Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease

¹ Department of Medical Genetics, Cambridge Institute for Medical Research, Wellcome/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0XY, UK
² Department of Genetics, University of Cambridge, CB2 3EH, UK

^* Author for correspondence (e-mail: dcr1000{at}hermes.cam.ac.uk)

Accepted 21 February 2008

Huntington disease (HD) is caused by a polyglutamine-expansion mutation in huntingtin (HTT) that makes the protein toxic and aggregate-prone. The subcellular localisation of huntingtin and many of its interactors suggest a role in endocytosis, and recently it has been shown that huntingtin interacts indirectly with the early endosomal protein Rab5 through HAP40. Here we show that Rab5 inhibition enhanced polyglutamine toxicity, whereas Rab5 overexpression attenuated toxicity in our cell and fly models of HD. We tried to identify a mechanism for the Rab5 effects in our HD model systems, and our data suggest that Rab5 acts at an early stage of autophagosome formation in a macromolecular complex that contains beclin 1 (BECN1) and Vps34. Interestingly chemical or genetic inhibition of endocytosis also impeded macroautophagy, and enhanced aggregation and toxicity of mutant huntingtin. However, in contrast to Rab5, inhibition of endocytosis by various means suppressed autophagosome-lysosome fusion (the final step in the macroautophagy pathway) similar to bafilomycin A1. Thus, Rab5, which has previously been thought to be exclusively involved in endocytosis, has a new role in macroautophagy. We have previously shown that macroautophagy is an important clearance route for several aggregate-prone proteins including mutant huntingtin. Thus, better understanding of Rab5-regulated autophagy might lead to rational therapeutic targets for HD and other protein-conformation diseases.

Key words: Huntington disease, Autophagy, Rab5

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

Related articles in JCS:

An autophagic role for Rab5

JCS 2008 121: 1002. [Full Text]  

This article has been cited by other articles:

				B. Ravikumar, M. Futter, L. Jahreiss, V. I. Korolchuk, M. Lichtenberg, S. Luo, D. C. O. Massey, F. M. Menzies, U. Narayanan, M. Renna, et al. Mammalian macroautophagy at a glance J. Cell Sci., June 1, 2009; 122(11): 1707 - 1711. [Full Text] [PDF]

				A. Huett, A. Ng, Z. Cao, P. Kuballa, M. Komatsu, M. J. Daly, D. K. Podolsky, and R. J. Xavier A Novel Hybrid Yeast-Human Network Analysis Reveals an Essential Role for FNBP1L in Antibacterial Autophagy J. Immunol., April 15, 2009; 182(8): 4917 - 4930. [Abstract] [Full Text] [PDF]

				A. Simonsen and H. Stenmark Self-eating from an ER-associated cup J. Cell Biol., August 25, 2008; 182(4): 621 - 622. [Abstract] [Full Text] [PDF]